Some people find it easier to maintain their new weight if they use a limited number of meal replacement products on an ongoing basis
The following are potential risks of biweekly dosing: The return of food noise The half-life of semaglutide is approximately 7 days, which means the concentration of semaglutide in the blood remains half after this period
clinical reports back up that early timing is common, as shown by Real-World Safety Concerns of Tirzepatide: A retrospective analysis of FAERS data published on September 9, 2025, reported that among 1,500 patients, 30% experienced nausea after starting tirzepatide
CagriSema is a play to increase the efficacy of semaglutide for weight loss and for A1C reduction in the setting of type 2 diabetes, said John B
Obesity and obstructive sleep apnea are linked
Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets